SEARCH

SEARCH BY CITATION

References

  • 1
    Godfrey, D. I., Stankovic, S. and Baxter, A. G., Raising the NKT cell family. Nat. Immunol. 2010. 11: 197206.
  • 2
    Novak, J. and Lehuen, A., Mechanism of regulation of autoimmunity by iNKT cells. Cytokine 2011. 53: 263270.
  • 3
    Lehuen, A., Diana, J., Zaccone, P. and Cooke, A., Immune cell crosstalk in type 1 diabetes. Nat. Rev. Immunol. 2010. 10: 501513.
  • 4
    Hammond, K. J., Pellicci, D. G., Poulton, L. D., Naidenko, O. V., Scalzo, A. A., Baxter, A. G. and Godfrey, D. I., CD1d-restricted NKT cells: an interstrain comparison. J. Immunol. 2001. 167: 11641173.
  • 5
    Gombert, J. M., Herbelin, A., Tancrede-Bohin, E., Dy, M., Carnaud, C. and Bach, J. F., Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse. Eur. J. Immunol. 1996. 26: 29892998.
  • 6
    Lehuen, A., Lantz, O., Beaudoin, L., Laloux, V., Carnaud, C., Bendelac, A., Bach, J. F. and Monteiro, R. C., Overexpression of natural killer T cells protects Valpha14- Jalpha281 transgenic nonobese diabetic mice against diabetes. J. Exp. Med. 1998. 188: 18311839.
  • 7
    Hammond, K. J., Poulton, L. D., Palmisano, L. J., Silveira, P. A., Godfrey, D. I. and Baxter, A. G., alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J. Exp. Med. 1998. 187: 10471056.
  • 8
    Sharif, S., Arreaza, G. A., Zucker, P., Mi, Q. S., Sondhi, J., Naidenko, O. V., Kronenberg, M., et al., Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat. Med. 2001. 7: 10571062.
  • 9
    Mizuno, M., Masumura, M., Tomi, C., Chiba, A., Oki, S., Yamamura, T. and Miyake, S., Synthetic glycolipid OCH prevents insulitis and diabetes in NOD mice. J. Autoimmun. 2004. 23: 293300.
  • 10
    Hong, S., Wilson, M. T., Serizawa, I., Wu, L., Singh, N., Naidenko, O. V., Miura, T. et al, The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat Med 2001. 7: 10521056.
  • 11
    Forestier, C., Takaki, T., Molano, A., Im, J. S., Baine, I., Jerud, E. S., Illarionov, P. et al., Improved outcomes in NOD mice treated with a novel Th2 cytokine-biasing NKT cell activator. J. Immunol. 2007. 178: 14151425.
  • 12
    Laloux, V., Beaudoin, L., Jeske, D., Carnaud, C. and Lehuen, A., NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen. J. Immunol. 2001. 166: 37493756.
  • 13
    Beaudoin, L., Laloux, V., Novak, J., Lucas, B. and Lehuen, A., NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic beta cells. Immunity 2002. 17: 725736.
  • 14
    Chen, Y. G., Choisy-Rossi, C. M., Holl, T. M., Chapman, H. D., Besra, G. S., Porcelli, S. A., Shaffer, D. J. et al., Activated NKT cells inhibit autoimmune diabetes through tolerogenic recruitment of dendritic cells to pancreatic lymph nodes. J. Immunol. 2005. 174: 11961204.
  • 15
    Naumov, Y. N., Bahjat, K. S., Gausling, R., Abraham, R., Exley, M. A., Koezuka, Y., Balk, S. B., et al., Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc. Natl. Acad. Sci. USA 2001. 98: 1383813843.
  • 16
    Lee, P. T., Benlagha, K., Teyton, L. and Bendelac, A., Distinct functional lineages of human V(alpha)24 natural killer T cells. J. Exp. Med. 2002. 195: 637641.
  • 17
    Gumperz, J. E., Miyake, S., Yamamura, T. and Brenner, M. B., Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 2002. 195: 625636.
  • 18
    Crowe, N. Y., Coquet, J. M., Berzins, S. P., Kyparissoudis, K., Keating, R., Pellicci, D. G., Hayakawa, Y., et al., Differential antitumor immunity mediated by NKT cell subsets in vivo. J. Exp. Med. 2005. 202: 12791288.
  • 19
    Michel, M. L., Keller, A. C., Paget, C., Fujio, M., Trottein, F., Savage, P. B., Wong, C. H. et al., Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J. Exp. Med. 2007. 204: 9951001.
  • 20
    Rachitskaya, A. V., Hansen, A. M., Horai, R., Li, Z., Villasmil, R., Luger, D., Nussenblatt, R. B. and Caspi, R. R., Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion. J. Immunol. 2008. 180: 51675171.
  • 21
    Michel, M. L., Mendes-da-Cruz, D., Keller, A. C., Lochner, M., Schneider, E., Dy, M., Eberl, G. and Leite-de-Moraes, M. C., Critical role of ROR-gammat in a new thymic pathway leading to IL-17-producing invariant NKT cell differentiation. Proc. Natl. Acad. Sci. USA 2008. 105: 1984519850.
  • 22
    Coquet, J. M., Chakravarti, S., Kyparissoudis, K., McNab, F. W., Pitt, L. A., McKenzie, B. S., Berzins, S. P., et al., Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population. Proc. Natl. Acad. Sci. USA 2008. 105: 1128711292.
  • 23
    Korn, T., Bettelli, E., Oukka, M. and Kuchroo, V. K., IL-17 and Th17 Cells. Annu. Rev. Immunol. 2009. 27: 485517.
  • 24
    Martin-Orozco, N., Chung, Y., Chang, S. H., Wang, Y. H. and Dong, C., Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. Eur. J. Immunol. 2009. 39: 216224.
  • 25
    Jain, R., Tartar, D. M., Gregg, R. K., Divekar, R. D., Bell, J. J., Lee, H. H., Yu, P., et al., Innocuous IFNgamma induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production. J. Exp. Med. 2008. 205: 207218.
  • 26
    Bending, D., De La Pena, H., Veldhoen, M., Phillips, J. M., Uyttenhove, C., Stockinger, B. and Cooke, A., Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J. Clin. Invest. 2009. 119: 565572.
  • 27
    Emamaullee, J. A., Davis, J., Merani, S., Toso, C., Elliott, J. F., Thiesen, A. and Shapiro, A. M., Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. Diabetes 2009. 58: 13021311.
  • 28
    Doisne, J. M., Becourt, C., Amniai, L., Duarte, N., Le Luduec, J. B., Eberl, G. and Benlagha, K., Skin and peripheral lymph node invariant NKT cells are mainly retinoic acid receptor-related orphan receptor (gamma)t+and respond preferentially under inflammatory conditions. J. Immunol. 2009. 183: 21422149.
  • 29
    Novak, J., Beaudoin, L., Griseri, T. and Lehuen, A., Inhibition of T cell differentiation into effectors by NKT cells requires cell contacts. J. Immunol. 2005. 174: 19541961.
  • 30
    Bluestone, J. A., Herold, K. and Eisenbarth, G., Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 2010. 464: 12931300.
  • 31
    Novak, J., Beaudoin, L., Park, S., Griseri, T., Teyton, L., Bendelac, A. and Lehuen, A., Prevention of type 1 diabetes by invariant NKT cells is independent of peripheral CD1d expression. J. Immunol. 2007. 178: 13321340.
  • 32
    Katz, J. D., Wang, B., Haskins, K., Benoist, C. and Mathis, D., Following a diabetogenic T cell from genesis through pathogenesis. Cell 1993. 74: 10891100.
  • 33
    Parekh, V. V., Wilson, M. T., Olivares-Villagomez, D., Singh, A. K., Wu, L., Wang, C. R., Joyce, S. and Van Kaer, L., Glycolipid antigen induces long-term natural killer T cell anergy in mice. J. Clin. Invest. 2005. 115: 25722583.
  • 34
    Cua, D. J. and Tato, C. M., Innate IL-17-producing cells: the sentinels of the immune system. Nat. Rev. Immunol. 2010. 10: 479489.
  • 35
    Han, G., Wang, R., Chen, G., Wang, J., Xu, R., Wang, L., Feng, J., et al., Interleukin-17-producing gammadelta+T cells protect NOD mice from type 1 diabetes through a mechanism involving transforming growth factor-beta. Immunology 2010. 129: 197206.
  • 36
    Aspord, C., Rome, S. and Thivolet, C., Early events in islets and pancreatic lymph nodes in autoimmune diabetes. J. Autoimmun. 2004. 23: 2735.
  • 37
    Feng, Y., Wang, D., Yuan, R., Parker, C. M., Farber, D. L. and Hadley, G. A., CD103 expression is required for destruction of pancreatic islet allografts by CD8(+) T cells. J. Exp. Med. 2002. 196: 877886.
  • 38
    Sarnacki, S., Begue, B., Buc, H., Le Deist, F. and Cerf-Bensussan, N., Enhancement of CD3-induced activation of human intestinal intraepithelial lymphocytes by stimulation of the beta 7-containing integrin defined by HML-1 monoclonal antibody. Eur. J. Immunol. 1992. 22: 28872892.
  • 39
    Hirota, K., Yoshitomi, H., Hashimoto, M., Maeda, S., Teradaira, S., Sugimoto, N., Yamaguchi, T., et al., Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J. Exp. Med. 2007. 204: 28032812.
  • 40
    Doisne, J. M., Soulard, V., Becourt, C., Amniai, L., Henrot, P., Havenar-Daughton, C., Blanchet, C., et al., Cutting edge: crucial role of IL-1 and IL-23 in the innate IL-17 response of peripheral lymph node NK1.1- invariant NKT cells to bacteria. J. Immunol. 2011. 186: 662666.
  • 41
    Thomas, H. E. and Kay, T. W., Beta cell destruction in the development of autoimmune diabetes in the non-obese diabetic (NOD) mouse. Diabetes Metab. Res. Rev. 2000. 16: 251261.
  • 42
    Miljkovic, D., Cvetkovic, I., Momcilovic, M., Maksimovic-Ivanic, D., Stosic-Grujicic, S. and Trajkovic, V., Interleukin-17 stimulates inducible nitric oxide synthase-dependent toxicity in mouse beta cells. Cell Mol. Life Sci. 2005. 62: 26582668.
  • 43
    Kawaguchi, M., Kokubu, F., Huang, S. K., Homma, T., Odaka, M., Watanabe, S., Suzuki, S., et al., The IL-17F signaling pathway is involved in the induction of IFN-gamma-inducible protein 10 in bronchial epithelial cells. J. Allergy Clin. Immunol. 2007. 119: 14081414.
  • 44
    Khader, S. A., Bell, G. K., Pearl, J. E., Fountain, J. J., Rangel-Moreno, J., Cilley, G. E., Shen, F., et al., IL-23 and IL-17 in the establishment of protective pulmonary CD4+T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 2007. 8: 369377.
  • 45
    Frigerio, S., Junt, T., Lu, B., Gerard, C., Zumsteg, U., Hollander, G. A. and Piali, L., Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis. Nat. Med. 2002. 8: 14141420.
  • 46
    Christen, U., McGavern, D. B., Luster, A. D., von Herrath, M. G. and Oldstone, M. B., Among CXCR3 chemokines, IFN-gamma-inducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-gamma (CXCL9) imprints a pattern for the subsequent development of autoimmune disease. J. Immunol. 2003. 171: 68386845.
  • 47
    Chen, Y. G., Chen, J., Osborne, M. A., Chapman, H. D., Besra, G. S., Porcelli, S. A., Leiter, E. H., et al., CD38 is required for the peripheral survival of immunotolerogenic CD4+invariant NK T cells in nonobese diabetic mice. J. Immunol. 2006. 177: 29392947.
  • 48
    Lee, P. T., Putnam, A., Benlagha, K., Teyton, L., Gottlieb, P. A. and Bendelac, A., Testing the NKT cell hypothesis of human IDDM pathogenesis. J. Clin. Invest. 2002. 110: 793800.
  • 49
    Honkanen, J., Nieminen, J. K., Gao, R., Luopajarvi, K., Salo, H. M., Ilonen, J., Knip, M., et al., IL-17 immunity in human type 1 diabetes. J. Immunol. 2010. 185: 19591967.
  • 50
    Moreira-Teixeira, L., Resende, M., Coffre, M., Devergne, O., Herbeuval, J. P., Hermine, O., Schneider, E., et al., Proinflammatory environment dictates the IL-17-producing capacity of human invariant NKT cells. J. Immunol. 2011. 186: 57585765.
  • 51
    Carnaud, C., Gombert, J., Donnars, O., Garchon, H. and Herbelin, A., Protection against diabetes and improved NK/NKT cell performance in NOD.NK1.1 mice congenic at the NK complex. J. Immunol. 2001. 166: 24042411.
  • 52
    Diana, J., Beaudoin, L., Gautron, A. S. and Lehuen, A., NKT and tolerance. Methods Mol. Biol. 2011. 677: 193206.
  • 53
    Diana, J., Brezar, V., Beaudoin, L., Dalod, M., Mellor, A., Tafuri, A., von Herrath, M., et al., Viral infection prevents diabetes by inducing regulatory T cells through NKT cell-plasmacytoid dendritic cell interplay. J. Exp. Med. 2011. 208: 729745.